AAM Announces New Regular Member and Board Member | Association for Accessible Medicines

AAM Announces New Regular Member and Board Member

WASHINGTON, DC (June 22, 2018) —The Association for Accessible Medicines (AAM) announced the approval of Hikma Pharmaceuticals as a Regular Member. Siggi Olafsson, CEO, will serve as Hikma’s representative on the AAM Board of Directors.

Generic drugs saved the U.S. health system $253 billion in 2016, according to the Generic Drug Savings in the U.S. report compiled by IQVIA on behalf of AAM.

A complete list of 2018 AAM Board of Directors can be found here. A complete list of 2018 AAM Regular Members can be found here.

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.